Kaplan–Meier analysis of overall survival in PAAD patients was performed according to low/medium or high CTL1 and CTL2 mRNA levels; the median of the data was used as the cut-off threshold. This evidence concerns the gene SLC44A1 and pancreatic adenocarcinoma.